THE USE OF CHIMERIC ANTIGEN RECEPTOR-ENGINEERED HESC- AND HIPSC- DERIVED T LYMPHOCYTES TO SPECIFICALLY TARGET AND ERADICATE HUMAN PROSTATE TUMORS IN

Weill Medical College Of Cornell University

Investigators